Addyi Isn't that Effective, and it Isn't Selling Very Well

The video provides an update on Addyi, also known as the female Viagra, discussing its controversial approval, limited effectiveness, and significant side effects. It highlights the drug's poor sales performance and the challenges faced by Valiant Pharmaceuticals, including high pricing and unmet sales forecasts. The FDA's requirements for risk management and additional studies are outlined, along with safety concerns related to birth control and other medications. The video concludes with a note on viewer support through Patreon.

What new insight or understanding did you gain from this video?